EG-626: Not a thromboxane A2 antagonist, but a PGI2 potentiator in platelet aggregation

This publication has 10 references indexed in Scilit:

• DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
  The Lancet, 1978
• De-aggregatory action of prostacyclin and its enhancement by theophylline
  Prostaglandins, 1978
• Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets
  Nature, 1977
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX)
  Prostaglandins, 1977
• Phosphodiesterase Inhibitors: Their Comparative Effectiveness in Vitro in Various Organs
  The Japanese Journal of Pharmacology, 1977
• Enhancement of Platelet Sensitivity to ADP-Aggregation by Isometric Exercise in Arteriosclerotic Patients and its Prevention
  Thrombosis and Haemostasis, 1977
• A Thromboxane A2-Antagonistic Effect of Pyridinolcarbamate and Phthalazinol
  Proceedings of the Japan Academy, 1976
• Hyperreactive Arterial Endothelial Cells in Atherogenesis and Cyclic AMP Phosphodiesterase Inhibitor in Prevention and Treatment of Atherosclerotic Disorders
  Japanese Heart Journal, 1975
• Prostaglandins released by the Spleen
  Nature, 1968